A comprehensive view of Respiratory/Lung Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Global bronchitis treatment market projected to grow by US$1.1B, have CAGR growth of 4.76%, from 2021 to 2026; growth driven by increase in smoking, as 32.51 million people smoked in US in 2020, 3.7 million smoke in Canada: Technavio
Published: August 02, 2022 by PR Newswire
Novartis cancels filing for FDA approval of tislelizumab to treat non-small cell lung cancer after FDA decision to delay review of drug as esophageal squamous cell carcinoma treatment; Novartis paid BeiGene US$650M for rights to drug outside China
Published: August 02, 2022 by Indian Pharma Industry : Policies
Global respiratory monitoring devices market expected to reach US$15.0B by 2021, with 6.3% CAGR growth from 2022-2031; growth driven by increase in chronic obstructive pulmonary disease, prevalence of obstructive sleep apnea
Published: July 25, 2022 by PR Newswire
Royalty Pharma buys royalty rights to GSK’s Trelegy Ellipta fluticasone furoate, umeclidinium, vilanterol from Theravance Respiratory for US$1.6B; Trelegy treats chronic obstructive pulmonary disease and asthma, had 2021 sales of US$1.7B
Published: July 19, 2022 by SeeNews Pharmaceuticals
Study finds inhaled corticosteroid asthma drug fluticasone furoate not effective against mild-to-moderate COVID-19; drug was one of three repurposed drugs being tested against COVID-19: Duke Clinical Research Institute
Published: July 18, 2022 by The Griffon News (Missouri Western State College)

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count